GlassScriptPhysician profile
Jaime A Caballero
NPI 1851524953
$20,811.92
in general payments reported to CMS, 2019-2025
55 companies · $1,967 in 2025
The $1,967 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,512 · 2020: $1,478 · 2021: $3,092 · 2022: $5,044 · 2023: $1,586 · 2024: $2,133 · 2025: $1,967.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,367 · Travel and Lodging: $301 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,367.48 |
| Travel and Lodging | $301.37 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $4,800.25 | 2019-2025 | Orsiro Mission, Biomonitor |
| Medtronic, INC. | $2,626.17 | 2021-2025 | Reveal Linq, Onyx Frontier, Corevalve Evolut R |
| Siemens Medical Solutions USA, INC. | $1,917.62 | 2019 | |
| Abbott Laboratories | $1,166.03 | 2021-2022 | |
| Medtronic Vascular, INC. | $1,155.04 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $881.27 | 2019-2025 | |
| Boston Scientific Corporation | $706.51 | 2019-2025 | Varithena Administration Pack, Lux-Dx Insertable Cardiac Monitor, General - Pain Management |
| Baylis Medical Company INC | $620.85 | 2019 | |
| Amgen INC. | $542.61 | 2019-2025 | Repatha, Repatha |
| Acist Medical Systems, INC. | $522.17 | 2019-2020 | |
| Abiomed | $452.54 | 2019-2023 | Impella |
| Pfizer INC. | $372.65 | 2019-2025 | |
| Shockwave Medical, INC | $345.36 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cathworks, INC. | $340.62 | 2024-2025 | Ffrangio |
| Cardiovascular Systems INC. | $308.70 | 2020-2022 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $305.26 | 2019-2025 | Kengreal, Cleviprex |
| Actelion Pharmaceuticals US, INC. | $293.95 | 2021-2025 | Uptravi |
| E.R. Squibb & Sons, L.L.C. | $275.31 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $264.00 | 2019-2024 | Xarelto |
| Penumbra, INC. | $256.72 | 2022-2024 | Indigo System |
| Alnylam Pharmaceuticals INC. | $244.35 | 2024-2025 | Onpattro, Amvuttra |
| Merck Sharp & Dohme LLC | $241.19 | 2021-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $231.43 | 2019-2025 | Lifevest |
| Philips North America LLC | $188.92 | 2020-2024 | (Ck4) Mcot |
| Astrazeneca Pharmaceuticals LP | $186.04 | 2020-2025 | Farxiga, Wainua |
| Novo Nordisk INC | $149.56 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lexicon Pharmaceuticals, INC. | $133.27 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $131.65 | 2021-2023 | Jardiance |
| Angiodynamics, INC. | $114.20 | 2024 | Auryon Laser System 100-120 Vac |
| Biom'Up Sa | $113.56 | 2019 | |
| Corindus INC. | $109.43 | 2019 | |
| Sanofi-Aventis U.S. LLC | $102.32 | 2020-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.49 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $70.31 | 2019-2024 | Evkeeza |
| Bard Peripheral Vascular, INC. | $52.00 | 2021 | |
| Biom'Up France Sas | $38.43 | 2020 | |
| Amarin Pharma, INC. | $37.99 | 2020-2021 | |
| Kerecis Limited | $33.47 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Recor Medical INC | $32.29 | 2024 | Paradise Renal Denervation System |
| United Therapeutics Corporation | $30.52 | 2025 | Tyvaso |
| Endotronix, INC. | $27.16 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Atricure, INC. | $26.68 | 2023 | |
| Corcept Therapeutics | $25.56 | 2025 | Korlym |
| Cvrx, INC. | $25.33 | 2022 | |
| Arbor Pharmaceuticals, INC. | $24.63 | 2021 | |
| Astellas Pharma US INC | $22.90 | 2022 | |
| Csl Behring | $22.82 | 2019 | |
| Livanova USA, INC. | $22.77 | 2023 | Protekduo |
| Azurity Pharmaceuticals, INC. | $21.01 | 2024 | Edarbi |
| Irhythm Technologies, INC. | $20.47 | 2022 | |
| Coala Life INC | $18.89 | 2020 | |
| Esperion Therapeutics, INC. | $16.63 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $16.08 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $16.03 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $12.91 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Caballero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.